Fraunhofer Institute for Cell Therapy and Immunology IZI
Video is loading ...
We transfer biomedical research into the clinic.
The Fraunhofer Institute for Cell Therapy and Immunology IZI investigates and develops solutions to specific problems at the interfaces of medicine, life sciences and engineering.
One of the institute's main tasks is to conduct contract research for companies, hospitals, diagnostic laboratories and research institutes operating in the field of biotechnology, pharmaceuticals and medical engineering.
The Fraunhofer IZI develops, optimizes and validates methods, materials and products for the business units Drugs, Cell Therapy, Diagnostics and Biobanks.
Its areas of competence lie in cell biology, immunology, drug biochemistry, bioanalytics and bioproduction as well as process development and automation.
In these areas, research specifically focusses on the indications oncology, ischaemia, autoimmune and inflammatory diseases as well as infectious diseases and regenerative medicine.
The institute works in close cooperation with hospital institutions and performs quality tests besides carrying out the GMP-compliant manufacture of clinical test samples. Furthermore, it helps partners obtain manufacturing licenses and permits.
Fraunhofer Institute for Cell Therapy and Immunology Celebrates Ten Year Anniversary in Leipzig
On April 29, 2015, over 300 guests from politics, business and science came together to celebrate ten years of Leipzig's first Fraunhofer institute. In all, the rapidly grown institute was given nothing but praise in every area. Over 500 members of staff work at the institute today. Almost 300 projects have been processed since being founded and more than 600 scientific papers have been published.